Results 141 to 150 of about 128,122 (265)

Diagnostic Guidelines for the Evaluation of Choledocholithiasis in Patients With Acute Biliary Presentations: A Study of Their Applicability and Feasibility in a Publicly Funded Healthcare System

open access: yesANZ Journal of Surgery, EarlyView.
ABSTRACT Background The American and European Societies of Gastrointestinal Endoscopy (ASGE and ESGE) have published diagnostic guidelines for the evaluation of choledocholithiasis. The applicability and feasibility of these guidelines in a publicly funded health care system, such as ours in Aotearoa New Zealand, are not known. This retrospective study
Henry C. K. Kwok   +3 more
wiley   +1 more source

Five Advances in Benign Pancreatic Surgery in the Last 50 Years

open access: yes
World Journal of Surgery, EarlyView.
Stephan B. Dreyer, Rowan W. Parks
wiley   +1 more source

Extracorporeal Albumin Dialysis (OPAL) as Novel Therapeutic Bridging Option in Posthepatectomy Liver Failure

open access: yesArtificial Organs, EarlyView.
Extracorporeal albumin dialysis (OPAL) effectively reduces bilirubin and improves other laboratory markers in posthepatectomy liver failure, particularly in secondary forms. It may serve as a bridging therapy to support hepatic recovery in critically ill patients, although prospective studies are needed to confirm its impact on survival.
Dorian Marckmann   +16 more
wiley   +1 more source

Natural History of Recurrent Acute Pancreatitis: Implications for Interventional Trial Design

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
In this nationwide cohort of 6894 patients with recurrent acute pancreatitis, recurrence risk increased progressively with each episode and occurred most frequently within the first year. Successive episodes were separated by shorter intervals, indicating an accelerating disease course and highlighting the importance of early preventive interventions ...
Søren S. Olesen   +7 more
wiley   +1 more source

Review Article: The Impact of the Gut Microbiome on Ulcerative Colitis Pharmacotherapy

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
The gut microbiome modulates ulcerative colitis pharmacotherapy through microbial drug metabolism, immune regulation and altered drug bioavailability. Microbial composition influences response to aminosalicylates, corticosteroids, immunomodulators, biologics and small molecules, while microbiome‐targeted therapies show emerging promise.
Kate Collins   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy